Evolution of the Average Target: Forvia (ex-Faurecia)

Evolution of the Target Price: Forvia (ex-Faurecia)

Changes in Analyst Recommendations: Forvia (ex-Faurecia)

91.YTEU33F2Tvt3JHqeqyAKkaHdmaPXVLWcoXKjcxta1nI.CkFg7UNEILFCYE397hBMp-6L2u-FN_js1RjwXk8MjEcDRECVH0YetkJ0Ow~283989c213596656472ef9a92fd162a7
Apr. 30 Forvia: EPS cut (2025: from € -0.46 to -7.78, 2026: from € 1.22 to 0.88) Alphavalue
Apr. 28 Jefferies applauds divestment of Forvia's Interiors business Zonebourse
Apr. 08 Berenberg Updates Forvia Model After Q1 Pre-close Call; Price Target Cut on Sector De-rating MT
Apr. 07 Forvia in the red as Berenberg forecasts 24% revenue drop for Q1 Zonebourse
Mar. 11 Forvia slips despite support from Citigroup Zonebourse
Mar. 04 Forvia: Resilient FY25 in a Tough Environment; Ambitious 2028 Targets Unveiled at CMD Alphavalue
Feb. 26 Analyst recommendations: Spotify, Gartner, Godaddy, Medline, Moderna… Zonebourse
Jan. 20 Forvia lifts EPS after Q4 pre-close Alphavalue
Nov. 25 Forvia revises EPS outlook after non-cash charge Alphavalue
25-10-21 Forvia: UBS Maintains Neutral Rating After Q3 Revenue in Line with Expectations Zonebourse
25-10-21 Forvia: UBS still neutral after quarterly results Zonebourse
25-10-20 Forvia: Q3 results impacted by geographic mix and FX headwinds; FY25 guidance confirmed Alphavalue
25-09-12 The stock market regains its cloak of invincibility Zonebourse
25-08-07 Forvia: Opinion change, from Sell to Reduce Alphavalue
25-07-30 Analysts' opinions of the day: Kering splits, news on Abivax, Soitec and Novo Nordisk Zonebourse
25-07-29 Forvia: Deutsche Bank downgrades stock Zonebourse
25-07-29 Forvia: Solid H1 results ahead of expectations, FY25 guidance confirmed Alphavalue
25-07-29 Forvia: Oddo BHF raises target price Zonebourse
25-07-24 Forvia: NAV cut by -14.8% Alphavalue
25-07-03 Forvia: Target upgrade by 14.5% Alphavalue
25-06-27 Forvia: Berenberg still a buyer, seeing positive surprises Zonebourse
25-04-22 FORVIA : Receives a Buy rating from Deutsche Bank ZD
25-04-22 Forvia: Oddo BHF lowers target price Zonebourse
25-04-17 Forvia: Stronger than expected Q1 and FY25 guidance maintained despite tariff risks Alphavalue
25-04-01 Forvia: Opinion change, from Buy to Reduce Alphavalue

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+56.53%
+35.92%
+27.5%
+14.98%
+17.52%
+40.69%
+1.93%
+8.75%
+8.7%
+5.24%
Average +21.77%
Weighted average by Cap. +21.79%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.560EUR
Average target price
14.96EUR
Spread / Average Target
+56.53%
High Price Target
39.00EUR
Spread / Highest target
+307.95%
Low Price Target
11.00EUR
Spread / Lowest Target
+15.06%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Adrien Brasey
TP ICAP Midcap
UBS David Lesne
Stifel Nicolaus
Berenberg Bank
GOLDMAN SACHS Philipp Konig
JEFFERIES Himanshu Agarwal
DEUTSCHE BANK RESEARCH Christoph Laskawi
JPMORGAN Jose Asumendi
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
9.560EUR
Average target price
14.96EUR
Spread / Average Target
+56.53%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FRVIA Stock
  4. Consensus Forvia (ex-Faurecia)
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!